SOLIGENIX, INC. — Director's Dealing 2017

Dec 11, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2017-12-07

Reporting Person: Straube Richard (SVP and CMO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-12-07	Option (Right to Buy)	$2.01	A	35000	Acquired	2027-12-06	Common Stock (35000)	Direct

Footnotes

F1: The stock option vested immediately as to 8,750 shares and vests as to the remainder at a rate of 2,187.5 of the shares on each three (3) month anniversary of December 7, 2017.